Updated 11/07/02

Please use the menu below to jump to a topic:
go button

New Genocidal AIDS Vaccine Experiments:

Don Francis, Genentech, Hoffman-La-Roche,

and The Rise of the Fourth Reich


Introduction by Dr. Len Horowitz

Author of "Emerging Viruses: AIDS & Ebola--Nature, Accident or Intentional?"

Don Francis, currently AIDS vaccine director at Genentech, was previously exposed by this author for his intimate connections to the U.S. Government agencies, programs, and people (including Max Essex and Robert Gallo) that created numerous AIDS-like and Ebola-like viruses during the "Special Virus Cancer Program" of the late 1960s and early 1970s. He was quoted in Randy Shiltz's book, "The Band Played On" as matter-of-factly citing the neglected AIDS link to the experimental hepatitis B vaccines given to gay men in New York and Blacks in Central Africa during the mid-1970s. Francis's links to U.S. military medical intelligence was also cited in "Emerging Viruses: AIDS & Ebola--Nature, Accident or Intentional?" (Tetrahedron Press, 1999; 1-888-508-4787) that curiously, despite being a bestseller, escapes mainstream media attention.


In the following article, Francis reveals his breach of ethics, and the Nurenberg Code, for risky, if not genocidal, AIDS vaccine experiments currently ongoing in Thailand. This, according to the article, is being funded by the World Bank and World Health Organization (WHO). Both of these organizations are largely funded by the Rockefeller and Royal Families.


The problem is, history links the Rockefeller, Bush, and Royal Families to: 1) the rise of contemporarly genocidal applications of drugs and chemicals--previously known as the eugenics (i.e., racial hygiene) movements in America and pre-Hitlerian Germany; and 2) to I.G. Farben. I.G. Farben was the international chemical and pharmaceutical cartel that was the economic might behind the Third Reich. A full fledged Rockefeller partner, the cartel was allegedly divested following WWII. Its assets were funnelled, Congressional records indicate, into the largest chemical and pharmaceutical companies throughout the world; in a manner that would assure business as usual. Included in I.G.'s business plan for the last half of the twentieth century was the successful rise of the "Forth Reich." Their records record this as the "neuordnung," that is "New Order," or to quote George Bush's State of the Union Address, the kinder and gentler "The New World Order."


Thus, here is an example of the ongoing medical genocidal agenda disguised as a "humanitarian" effort to save the world from AIDS. As you read the following London Sunday Times article, keep in mind that Don Francis, exposed here as he really is, is perfect for the job he commands as AIDS vaccine director at Genentech, a subsidiary of Hoffman-La-Roche. This company, according to Congressional Records and reputable cancer investigator and author Ed Griffin (See: World Without Cancer, American Media Press, 1997) was intimately linked to I.G. Farben.


Read this and weep!


>THE LONG SHOT (Sunday Times magazine)

>Dr Donald Francis hopes his vaccine will prevent Aids.  He is backed by

>the World Bank and the World Health Organisation.  But Sunday Times'

>Brian Deer has uncovered disturbing evidence that it could be

>ineffective or, worse, hasten the onset of Aids in some people. The

>article, published today, states (extracts follow):


>Unlike ebola, a rare disease, HIV has slain 14m people and infected

>another 35m.  And unlike the hepatitis B virus, which is quite stable,

>HIV is a so-called 'retrovirus', with its genes coded in ribonucleic

>acid (RNA), and changes so much with each replication that it breeds an

>infinity of strains. So far, some three dozen would-be vaccines have

>been tested in labs, animals, or a few individuals, but none has done

>any good.  Vaccines work by priming our immune systems - including

>antibodies and T-cells - so that they will be ready for action if a bug

>comes along.  But so far, every attempt

>to accomplish this with HIV has proved either dangerous or to have no

>effect.  Some experts say that nothing will work.


>On March 24, the first of 1250 HIV-negative Thai volunteers started on a

>>course of seven six-monthly shots.  Another 1250 are getting a placebo.

>>The US government's National Institute of Health and its Food and Drug

>>Administration (FDA), both in Maryland, are backing the experiment.  So

>>are officials of the World Bank in Washington and United Nations

>>agencies. (The vaccine developer) VaxGen is one quarter-owned by

>>Genentech Inc, a medical biotechnology leader.  Genentech is a subsidiar

>>of Hoffman-La-Roche, the Swiss pharmaceutical colossus.  All are poised

>>for full-scale production.  When shares in the company were launched on

>>the New York Nasdaq market at the end of July, they jumped from $13 to



>At first glance, Thailand is a strange place to carry out medical

>trials.  The CIA rates the country as merely an 'emergent democracy';

>the last military coup was only eight years ago; and there were Bangkok

>riots in 1992, when 91 died or went 'missing'.  Corruption is de

>rigueur, while police are accused by Amnesty International of

>'extra-judicial killings'. Much of its profile relies on prostitution -

>first with young women and later with children.  Since the coup,

>however, quick, cheap experiments on

>the Thai population have been added to the country's attractions.


>Dozens of projects are currently in progress, run by foreign

>pharmaceutical companies and sponsored by the CDC and WHO.  With an

>estimated 800,000 Thais infected with HIV, Aids is the big one, with

>tests of drugs, immune-system stimulants and, top of the list, Francis's

>AidsVax trial. Some volunteers on the AZT trial were mothers from remote

>hill tribes.   "They don't speak Thai, so there is the question of

>whether they can understand enough to give informed consent".


>(An activist from the northern town of Chiang Mai told the reporter)

>Despite grilling 11 people who swallowed tablets daily, he complained

>that he couldn't discover even the name of the product or the

>pharmaceutical company involved.  This man was a former heroin user, so

>I asked him where VaxGen was recruiting.  "Go to Khlong Toei," he said.

>"By Port Authority building. That's where they'll get people for the

>trial." Khlong Toei is a slum; a sewage-stinking wasteland; a cauldron

>of disease and drug use.  At night, frail figures shuffle around,

>suffering from Aids, tuberculosis or both.


>(Aids prevention has been slashed by one-third against comparable health

>programmes, with the biggest cuts in initiatives aimed specifically at

>drug users.)  The journalist asks:  "Were these changes evidence that

>the government was allowing the junkies to be put at greater risk to

>make them useful for experiments?  (Health department officials told me

>that if AdisVax is marketed, they expect a billion-dollar manufacturing

>plant.) I couldn't find out.  People wouldn't talk when I raised such

>contentious concerns.  Even Bangkok's Medecins Sans Frontieres staff

>went silent when asked about the trial."


>He continues:  The junkies get methadone liquid, an oral heroin

>substitute, plus $10 expenses for each of up to 17 visits.  The risk is

>the appearance of offering drugs and money as inducements to this

>desperate group. Visitors are impressed (at the project).  But the

>science expounded in the journal issue doesn't convince people who grasp

>the detail.  "It's a waste of time," Dr Robert Gallo, America's

>pre-eminent retrovirologist, told me. Professor Andrew McMichael, Aids

>vaccine chief at Oxford University's Institute of Molecular Medicine,

>said, "I wouldn't have the belief that this will work."  And Dr

>Jean-Paul Levy, head of France's vaccine programme, spat: "It forgets

>one century of science."


>At the American government's Los Alamos National Laboratory in New

>Mexico, staff track amino acid sequences for thousands of HIV strains.

>And when I asked them to print their data from Thailand, a startling

>contradiction emerged.  The B component in AidsVax B/E - the shots being

>given to the Junkies - has the New Jersey V3 loop tip sequence.  It goes

>GPGRAF.  According to Bergman's argument, the local B strains would need

>to have the

>same string of beads.  But only 10% of Thai B strains have the New

>Jersey amino acid sequence.  Far more often - in nearly half the strains

>-  there are two different beads in the loop's tip: glutamine (Q), and

>tryptophan (W).  They are GPGQAW.  By Berman's reasoning, the Bangkok

>junkies are  being injected with the WRONG vaccine.


>Every six months, a 10-strong committee of doctors and scientists crowds

>into VaxGen's boardroom.  This is the 'data safety and monitoring board'

>recruited to keep an eye on the experiment.  .... the committee's brief

>is to watch for just 30% effectiveness.  Such is the threat from Aids,

>it's argued, that this figure is enough for success.


>I asked a professor of medical statistics to number crunch this

>percentage. To reach 30%, he said, there would only need to be 28 more

>infections among junkies on the placebo than among those receiving

>AidsVax....But could such bodies as the FDA and the European Medicines

>Evaluation Agency license a vaccine that doesn't really work, on the

>basis of an AZT-style blip?  Evidence suggests that agencies under


>pressure take just such paradoxical steps.



>the National Institutes of Health, for instance, vetoed the VaxGen

>experiment as a waste of money and volunteers.  But after being accused

>of a 'human rights violation' by Dr Jonathan Mann, 51, former WHO Aids

>chief (who died with his wife, Dr Mary Lou Clements-Mann in the Swissair

>crash), the institutes not only reveresed themselves but granted Francis

>$4.6 million. (CO'Driscoll comments:  "I wondered who was on board that

>plane when I heard about the crash.")


>The Journal of Aids Research and Human Retroviruses has an editorial

>board that's a Who's Who of Aids.  But Francis paid the publisher

>$10,000 for the 'special issue' which Berman edited as a 'guest'.  As

>for some of the contributors, Francis helped to set up Berkley's

>international vaccine initiative and advised Bill Gates's charity

>foundation to give it $25 million.  And he has offered the CDC's Heyward

>the post of VaxGen vice president starting next January.


>Mass immunisation is what they (CDC) know best.  It's simply what they

>do. "Don Francis reminds them of when they were young," Dr John Moore of

>New York's Aaron Diamond Aids Research Center, told me.  What worries

>critics such as Moore is that political and institutional pressures may

>lead to millions of people being injected with AidsVax before the

>benefits and risks are clear. The WHO estimates that the annual demand

>for the first vaccine will be 650m doses, and Unicef leaders are

>thinking about adding it to

>programmes for 100m children. (The journalist had two interviews with

>Francis.  In the second, the following dialogue took place):


>I asked him to explain the anomaly with the vaccine.  The amino acid

>stuff.  If Bergman's theory about V3 loop tips was correct, then surely

>the gp120 from the New Jersey strain would not do much good in Bangkok.

>Francis had an answer.  True, the V3 tip on the B part of the vaccine

>wasn't the same as the Bs in circulation.  But, he said, it was the same

>as on the other prevalent strains - the Es.  It would work on them.  "It

>happens to be identical to the Thai E that's in the vaccine," he said.

>But this wasn't right.  What he said wasn't true.


>"No it's not," I interrupted.


>"Yeah," he insisted.


>"No it's not."


>"It is."


>I rummaged through my papers and read him the amino acid strings from

>the V3 tip on the gp120 blob.  It was barely 100-millionth the size of

>the infected cell, but not quite out of sight.  "Here we are: Thai E

>strain is GPGQVF."


>"Right," he agreed. "the Thai B strain is GPGQAW," I continued.  "If you

>take the B vaccine sequence, it's GPGRAF." The strings were all

>different.  He was talking nonsense.  "Okay, okay," he acknowledged,

>"I'm sorry."


>That surprised me.  Lives were at stake.  "But you're not giving the

>Bangkok junkies the most promising product, by your own reasoning."

>"For the B virus?" he said.  "Possibly. That possibly could be true."


>"Isn't it unethical?"


>"No"  He paused.  "No, because it would be unethical if you told them

>that this vaccine was going to work.  We tell them to assume no



>Ah, yes.  Later I put to him the safety issue and the fact that serious

>opinion suggested that AidsVax could have long-term risks.  "I think you

>have to have a theoretical rationale why it would cause harm," he



>"There ARE theoretical rationales."


>"Where?" he snapped.


>I cited the 'deceptive imprinting' work of Kohler in Kentucky as one

>example.  "The question that you are asking," he said, "is: if you get

>infected, subsequently to immunisation, will you have an increased

>disease manifestation, or harm accrue from the vaccine?  And that could

>be.  That could be."  Nobody was telling the Bangkok junkies.  "Don't

>you think some of these doubts should be made plain in the informed

>consent?" I asked.


>"I think it's more important to say, 'We don't know,'" he responded

>irritably.  "And that's what we say.  And we say, 'Do not depend on this

>vaccine.  We do not know if it has effect, if any, and that's why we are

>studying it.'  I think that's your ethical responsibility - to really

>say, 'We do not know.  We do not know if it will cause harm. These are

>the data that we have.'"


>HIV was uniquely dangerous, he said, with 16,000 new infections daily.

>There was no way to develop the desperately needed vaccine that didn't

>involve taking risks.


>I said:  "But the fact that this is an extremely virulent and infectious

>agent doesn't entitle you to be reckless."


>"Agreed," he hit back.  His voice was rising.  "But shouldn't it

>stimulate society to take chances to prevent it?"  He said that vaccine

>developers had always taken risks, sometimes proportionately even

>greater for less threatening parasites, such as in measles or

>pertussis.  "We have taken the potential risk to deal with diseases that

>have very low mortality rates," he shouted, stabbing his finger.  "With

>HIV, at least you have the luxury that this bug is so f****ing dangerous

>that it kills everybody - that all YOU can say is that what I would do

>to these people is shorten their incubation period, which would be a

>tragedy."  He glowered at me.  Now he'd lost it. It was character

>revealed by stress.  "But I'm not going to kill any more people than the

>virus has already killed."


>Catherine O'Driscoll

>Canine Health Concern


Posted and transmitted by:

Tetrahedron Publishing Group,

P. O. Box 2033

Sandpoint, ID 83864